Prolaris has been validated in multiple clinical studies, demonstrating its ability to predict prostate cancer outcomes. It is recognized by various medical societies and guidelines as a useful tool in prostate cancer management. However, it is important to consider it as part of a comprehensive diagnostic approach.
